All-Trans Retinoic Acid Induces Differentiation of Ducts and Endocrine Cells by Mesenchymal/Epithelial Interactions in Embryonic Pancreas
- Sidhartha Singh Tulachan,
- Ryuichiro Doi,
- Yoshiya Kawaguchi,
- Shoichiro Tsuji,
- Sanae Nakajima,
- Toshihiko Masui,
- Masayuki Koizumi,
- Eiji Toyoda,
- Tomohiko Mori,
- Daisuke Ito,
- Kazuhiro Kami,
- Koji Fujimoto and
- Masayuki Imamura
- From the Department of Surgery and Surgical Basic Science, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Abstract
Retinoids during the embryonic period act as a mesenchymal inducer in many organs, including kidney, lung, central nervous system, and gut. Retinoic acid (RA) demonstrates insulinotropic effects in adult pancreas, but only a limited study has elucidated its role in pancreatic organogenesis. In this study, we have analyzed the existence of RA-signaling machinery in embryonic pancreas and evaluated its role using in vitro tissue culture experiments. Here we show the presence of endogenous retinaldehyde dehydrogenase 2 (RALDH2), the most effective RA-synthesizing enzyme, RA-binding proteins, and RA receptors (RARs) in embryonic pancreatic tissue. RALDH2 is expressed exclusively in the mesenchyme. Exogenously added all-trans-retinoic acid (atRA) in tissue culture experiments stimulated differentiation of endocrine and duct cells and promoted apoptotic cell death of acinar tissue. Furthermore, we demonstrate that atRA upregulates the PDX-1 expression. Taken together, our data suggest that atRA-mediated mesenchymal/epithelial interactions play an important role in determining the cell fate of epithelial cells via regulation of the PDX-1 gene, leading to the proper formation of the endocrine versus exocrine component during pancreatic organogenesis.
Footnotes
-
Address correspondence and reprint requests to Ryuichiro Doi, MD, Department of Surgery and Surgical Basic Science, Graduate School of Medicine, Kyoto University, 54 Shogoin, Kawara cho, Sakyoku, Kyoto 606-8507, Japan. E-mail: doir{at}kuhp.kyoto-u.ac.jp.
Received for publication 8 June 2002 and accepted in revised form 23 September 2002.
atRA, all-trans retinoic acid; COUP-TF II, chicken ovalbumin upstream promoter transcription factor II; CRABP II, cellular retinoic acid binding protein II; PE, pancreatic epithelia only; PEM, pancreatic epithelia with mesenchyme; RALDH2, retinaldehyde dehydrogenase 2; RA, retinoic acid; RAR, retinoic acid receptor; RARE, retinoic acid responsive element.
- DIABETES











